Position in EBS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,542,904
-$789,565 QoQ
Shares Held
900,108
-10.3% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 194 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Derivatives in EBS
reported options exposure · as of Jun 30, 2021CallValue
$258,259
CallShares
4,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. EBS ranks #20 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in EBS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,542,904 | 900,108 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,332,469 | 1,003,912 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,938,961 | 723,217 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,832,692 | 321,167 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,624,527 | 411,368 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,323,251 | 272,274 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,661,890 | 383,043 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,439,002 | 771,138 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,645,568 | 827,796 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,054,159 | 416,664 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,847,724 | 1,186,552 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,184,161 | 936,518 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,187,689 | 977,917 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,128,760 | 1,363,780 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,269,408 | 1,631,618 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $20,826,550 | 992,213 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $33,086,994 | 1,065,947 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $47,776,840 | 1,163,586 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $41,093,842 | 945,338 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,126,621 | 62,445 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $258,259 | 4,100 | Call | Defined | 2021-08-16 | |
| 2021-06-30 | $604,263 | 9,593 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $1,163,993 | 12,991 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $629,002 | 7,954 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,641,713 | 45,657 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||